Today's most important downgrades

Keefe, Bruyette & Woods downgraded Jefferies Group (NYSE: JEF) to Market Perform from Outperform ahead of the upcoming Q4 results announcement on Jan 9, 2023. Shares were down more than 4% intra-day.

Oppenheimer downgraded Fate Therapeutics (NASDAQ: FATE) to Perform from Outperform as part of a broader downgrade on the NK-cell therapy space. Shares fell more than 10% intra-day today.

Oppenheimer downgraded Celularity (NASDAQ: CELU) to Perform from Outperform. Shares were trading more than 8% lower intra-day today.

By Davit Kirakosyan

Want this type of news in real-time as it happens? Upgrade to StreetInsider.com Premium Here

You May Also Be Interested In

• Bark Inc. (BARK) PT Raised to $19 at Jefferies Following 20:1 Reverse Split
• Jefferies sees a buying opportunity in this steel stock
• Macy’s, Inc. to Participate in Jefferies Consumer Conference